Consumer Packaged Goods & Pharmaceuticals · Advertiser / Brand
URSAPHARM
German ophthalmic pharmaceutical manufacturer with international distribution.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- URSAPHARM Arzneimittel GmbH
- Entity type
- COMPANY
- Founded
- 1974
- Headquarters
- Germany
- Company size
- 501–1,000
- Market cluster / sector
- Consumer Packaged Goods & Pharmaceuticals
- Market role
- Advertiser / Brand
- Official website
- ursapharm.de
What URSAPHARM does
URSAPHARM creates value by developing, manufacturing and commercialising pharmaceutical and related healthcare products, with a strong concentration in ophthalmology. It monetises through physical product sales distributed via pharmacies, healthcare providers and country-level commercial channels. Its owned digital content supports awareness, education and downstream product demand, reinforcing core product sales rather than operating as a separate digital business line.
Category differentiation
URSAPHARM is a pharmaceutical and medical products manufacturer, not an adtech, martech or healthcare software vendor. Its digital magazine is a branded education property, not a standalone publisher monetised through advertising.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
URSAPHARM Arzneimittel GmbH is a German family-owned pharmaceutical manufacturer focused on ophthalmology, alongside medicinal products, medical devices and food supplements. The company operates from Germany and serves multiple international markets through local country domains, subsidiaries and distribution channels. Its core business is the development, manufacture and sale of healthcare products rather than software, advertising technology or media services. URSAPHARM generates revenue from product sales into healthcare and pharmacy channels. Its digital assets support education and brand communication, including a consumer-facing eye-health magazine integrated into its website, but these properties function as demand support rather than standalone monetisation businesses. Its direct customers are healthcare-system intermediaries and professional channels, while end users include patients and consumers purchasing ophthalmic and related health products.
Business model & monetisation
URSAPHARM monetises primarily through one-off sales of pharmaceutical products, medical devices and food supplements. Commercial revenue flows through pharmacy, healthcare and distribution channels across Germany and other international markets. Its website and educational content act as marketing and patient-information tools that support product demand and brand equity rather than subscription, advertising or SaaS revenue.
- Pharmaceutical product sales
- One-time Sale
- Medical device sales
- One-time Sale
- Food supplement sales
- One-time Sale
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for URSAPHARM
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
URSAPHARM und der FC Bayern bauen erfolgreiche Partnerschaft weiter aus
Recorded impact score: 3.5/5
Die URSAPHARM Arzneimittel GmbH und der FC Bayern München setzen ihre erfolgreiche Zusammenarbeit fort. Mit HYLO®, dem marktführenden Sortiment im Bereich der Befeuchtung trockener Augen, bleibt URSAPHARM bis 2029 Gold Partner der ersten Herrenmannschaft des deutschen Rekordmeisters. Gleichzeitig wird die Partnerschaft strategisch ausgebaut: Neben einer stärkeren Ausrichtung auf die asiatischen Märkte […]
Explore company relationships
Questions about URSAPHARM
What is URSAPHARM?
URSAPHARM is a German family-owned pharmaceutical manufacturer specialising in ophthalmology, medical devices and related health products.
Who uses URSAPHARM?
Its products are bought through pharmacies, distributors and healthcare providers, and ultimately used by patients and consumers, especially in eye care.
How does URSAPHARM make money?
It makes money by selling pharmaceutical products, medical devices and food supplements through healthcare and pharmacy distribution channels.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
9 publicly documented primary sources and citations linked across the market graph.
Continue your research on URSAPHARM
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.
Unlock full intelligence profile, ownership & live market signals